Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

MAYNE PHARMA GROUP LIMITED

INVESTOR PRESENTATION - MAYNE PHARMA GROUP LIMITED

ASX:MYX

MAYNE PHARMA GROUP LIMITED

Health Care

Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010

Read more

Market Cap

537.30m

Price at Close

$0.32

4w avg. Volume

4.33m

4w avg. Turnover

$1.46m

Announcements
announcementt+2 movementdate
  • Becoming a substantial holder

    Shareholder Details

  • +3.13%

    14 Oct 2020

+3.13%

14 Oct 2020
  • 2020 Annual General Meeting

    Notice Of Meeting

  • +3.13%

    14 Oct 2020

+3.13%

14 Oct 2020
  • Appendix 4G

    Periodic Reports

  • -1.54%

    08 Oct 2020

-1.54%

08 Oct 2020
  • 2020 Corporate Governance Statement

    Periodic Reports

  • -1.54%

    08 Oct 2020

-1.54%

08 Oct 2020
  • Annual Report to shareholders

    Periodic Reports

  • -1.54%

    08 Oct 2020

-1.54%

08 Oct 2020
  • Mayne Pharma provides update on Women's Health pipeline

    Progress Report · Market sensitive

  • -15.79%

    05 Oct 2020

-15.79%

05 Oct 2020
  • Appendix 3G

    Issued Capital

  • +1.30%

    28 Sep 2020

+1.30%

28 Sep 2020
  • Mayne Pharma appoints new CFO

    Company Administration

  • +1.30%

    28 Sep 2020

+1.30%

28 Sep 2020
  • Appendix 3G

    Issued Capital

  • +2.67%

    21 Sep 2020

+2.67%

21 Sep 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • -1.47%

    02 Sep 2020

-1.47%

02 Sep 2020
Market Data

Current Price

$0.32

52WK HIGH

$0.595

52WK LOW

$0.195

1YR RETURN

-45.30%

1YR RETURN VS. SECTOR

-67.08%

90 DAY RETURN

-22.89%

ASX RANK

353

/2,008

SECTOR RANK

2

/31

SHARES OUTSTANDING

1.68b
ASX:MYX

MAYNE PHARMA GROUP LIMITED

Health Care

Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010

Read more

Market Cap

537.30m

Price at Close

$0.32

4w avg. Volume

4.33m

4w avg. Turnover

$1.46m

ASX:MYX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.